About
Brightmind.AI is a neurotechnology company based in Vienna, Austria, founded in 2022. The company aims to enhance brain health through personalized, AI-driven neuromodulation therapies that patients can use at home. Initially focusing on chronic migraines, Brightmind.AI plans to expand its offerings to address other neurological conditions, including dementia and depression. The core product is an FDA-cleared, at-home repetitive Transcranial Magnetic Stimulation (rTMS) device designed for chronic migraine patients. This non-invasive device utilizes AI-powered real-time EEG monitoring to predict migraine attacks and personalize treatment, achieving significantly higher efficacy in reducing migraine days compared to existing options. Brightmind.AI operates on a subscription model, providing telehealth services for patient onboarding and support. The company also collaborates with healthcare providers and conducts clinical trials to validate its technology and explore future applications in cognitive disorders.
Technologies
Keywords
Company Information
-
Employees 3
-
Founded 2022
Location
3 Sonnenfelsgasse, Vienna, Vienna, Austria, 1010